中国缩短与西方干细胞研究差距

当前位置：首页 > 英语口译

中国缩短与西方干细胞研究差距

天之聪教育 2012-06-19 未知 331次

听力、脑记、笔记训练材料，未注册用户都是没有办法使用的，可惜！

韩刚，毕业于外交学院英语翻译理论与实践专业，曾以优异成绩考入外交部翻译室接受培训，后调任新闻司担任新闻发言人同传，也是著名的口译教学老师。

中国缩短与西方干细胞研究差距

Tuesday, May 17, 2011

全球多个地方都有干细胞研究，但由于政府监管严格，加上不断引发道德争议，令实验工作受到阻碍。但在中国，这些因素并不存在，因此干细胞研究并没有受到限制，经过五年来大力投入，中国与西方的差距正大幅收窄。

《中国医学论坛报》表示，十年前中国在知名期刊发表的干细胞研究论文有37篇，到2008年已达到1,116篇。现在中国申请的干细胞专利和发表的研究论文数目均位列全球第五，增长步伐超过任何其它国家。

胚胎干细胞研究在西方引发争议，但在中国，相关研究工作却大幅迈进，并获得政府投入数十亿元，希望能找到创新治疗方法，对付心脏病、肝弘I竭和帕金逊病等慢性致命疾病。香港大学干细胞及再生医学组主任李登伟教授表示，中国整体上对生物医学大举投入，尤其是干细胞研究，这不仅可展示其作为科技大国的实力，也是最终实现知识型经济的手段。

他指出，同其它科学学科一样，中国干细胞研究的质量参差不齐，但仍有出色的成果，部分还发表在国际知名的专业期刊上。整体上，中国的研究趋势明显处于上行轨道。

China closes stem-cell gap with the West

Beijing's aggressive investment in a controversial branch of science pays dividends after just five years, but research fever also raises ethical concerns.

China's aggressive drive to close the gap with the West in stem-cell research is paying off after five years of heavy investment in a branch of science free of the tight regulatory constraints and intense debate over moral issues that hamper experimental work elsewhere.

A decade ago, China had 37 stem-cell research papers published by reputable journals. By 2008, it was 1,116, the China Medical Tribune said. It now ranks fifth in the world in both the number of stem-cell patents filed and research papers published. And its numbers are growing faster than in any other nation.

While research into embryonic and fetal stem cells sparked public controversy in the West, Beijing is charging ahead at a full speed. The government has poured billions of yuan into the research hoping to find innovative cures to chronic and deadly illnesses such as heart disease, liver failure and Parkinson's disease.

"China is aggressively investing in biomedical sciences in general, and particularly stem-cell research. Not only will it serve as a way to flex its muscle as a technological powerhouse but also a means to ultimately bring forth a knowledge-based economy," said Professor Ronald Li, director of the Stem Cell and Regenerative Medicine Consortium at the University of Hong Kong.

"As in other scientific disciplines, the quality of stem-cell research in China varies quite significantly. However, there are high-quality works being done and some have been published in high-profile international peer-reviewed journals. Overall, the trend is clearly on an upward trajectory."